III International Conference on Novel Psychoactive

RI A
15-16 Maggio 2014
Roma, Italia
HI
ITA
LIAN
A
AT
À
ET
SO CI
II Forum Internazionale
Changes in Psychiatry
DI P
S IC
III International Conference
on Novel Psychoactive Substances (NPS):
Focus 1: Update in Psychopharmacology, Comorbidity Treatment,
Pharmacological Interactions, Side effects management
Focus 2: “NPS and New Behavioural Addictions”
PRELIMINARY PROGRAMME
Thursday, May 15th
PARALLEL SESSIONS
Focus 1
Advanced course of psychopharmacology Focus on
Bipolar, Schizophrenia, Depression, Comorbid Drug
Abuse and Mental Illness. Polypharmacy, polypharmacy
interaction and side effect managment
Welcome
Paolo Girardi, Dario Carrus, Ornella Corazza
9.00
Introduction /Chairs
9.30
The art and science of combining medications
10.00
Emerging Novel Psychoactive Substances Related Disorders: The
Psychopathological Perspective.
Fabrizio Schifano - Giuseppe Ducci
Andrea Fagiolini
18:00 11.00
Paolo Girardi
Addiction and induced phenomena: which pharmacological strategy?
12.15
Questions time: The management of complex patient.. Between
psychosis, affective disorders and addiction.
Third International Conference on Novel Psychoactive Substances
Thursday, May 15th
Focus 2
Location: Domus Pacis Torre Rossa
10:00 Establishing the pattern of acute toxicity associated with novel
psychoactive substances
Paul Dargan
Cannabis, ‘Skunk’ and ‘Spice’: implications for mental health?
10:40 Novel Psychoactive Substances: a comparison among psychosis
11:00
11:30 Break - Poster Session
From club to clinic. What every clinician needs to know about Novel
Psychoactive Substances harms and treatment
Designer Drugs, Synthetic Cannabinoids and the US Federal Analog Act
12:10 CNS (Central Nervous System) stimulant drugs: why they are damaging
to recreational users
Recent changes in drug scenarios; clinical and clinical pharmacological
issues
Using media to monitor the global spread of Novel Psychoactive Substances
15:50
New drugs, old stories: Novel Psychoactive Substances, the media and
responsible communications
Ornella Corazza
Matthew Young
Harry Shapiro
16:10 Break
Lunch – Poster Session
PARALLEL SESSIONS
Sabrina Levissianos
15:30 David M. Benjamin
Andy Parrott
12.30
Drugs on Internet: a phenomenon out of control?
Giovanni Martinotti
Owen Bowden-Jones
The UNODC Early Warning Advisory on Novel Psychoactive Substances
– new trends
15:10
Robin Murray
11:50 14:30 Fabrizio Schifano
Ana Gallegos
10:20 Welcome – Opening
The past, present and future of new drugs
14:50 Plenary Opening
The European Early Warning System
14:00 14:10 Paul Griffiths, Roumen Sedefov
Day Closure
9:40 Registration
Chairs: Paolo Girardi, Dario Carrus, Roumen Sedefov, Ana Gallegos,
Ornella Corazza, Fabrizio Schifano
Chairs: Dario Carrus, Ana Gallegos, Giovanni Martinotti, Luigi Janiri,
Giuseppe Bersani
Chairs: Paolo Girardi, Dario Carrus, Massimo di Giannantonio, Paul Griffiths,
Sabrina Levissanos, Ruri Kikura-Hanajiiri
Giovanni Martinotti
Discussant: Fabrizio Schifano, Sergio De Filippis, Alessandro Vento
13:00
9:30 The management of complex patient.. Between psychosis, affective
disorders and addiction
Sponsored by Otsuka
Parallel Session II
Clinics and Therapeutics - COMUNICAZIONI ORALI
Location: Domus Pacis Torre Rossa
Simposio
Introduction/Chair
Chairs: Karine Dietrich, Ornella Corazza, Massimo di Giannantonio,
Harry Shapiro, Matthew Young
Friday 16th May 2014
Gilberto Di Petta
Pausa
Parallel Session I
Media and Knowledge Exchange - COMUNICAZIONI ORALI
Parallel Session I
Pharmacology , Toxicology and Policies - COMUNICAZIONI ORALI
Chairs: Fabrizio Schifano, Paolo Giradi, Andy Parrott, Giuseppe Bersani,
Robin Murray
Parallel Session II
New Substances, New Trends, New Solutions - COMUNICAZIONI ORALI
15:30
Conference closure
Chairs: Giovanni Martinotti, Karine Dietrich, Dario Carrus, Matthew Young,
Ornella Corazza
Faculty
Informazioni generali
Prof. David M. Benjamin
Scientific organisers
Psichiatra -Professor Tufts Medical School in Boston - Adjunct Associate Professor
at Northeastern University Northeastern University Boston, USA
Prof. Owen Bowden-Jones
Psichiatra - Consultant in Addiction Psychiatry and Honorary Senior Lecturer at
Imperial College - Division of Brain Science. Chair of the Faculty of Addictions at the
Royal College of Psychiatrists Imperial College of London,London, UK
Dr Ornella Corazza, University of Hertfordshire
Dr Dario Carrus, Sapienza University of Rome
Prof Fabrizio Schifano, University of Hertfordshire
Scientific committee
Antropologa - Academic Research Lead & Principal Lecturer in Mental Health and
Psychiatric Practice - Department of Postgraduate Medicine, School of Life and
Medical Sciences University of Hertfordshire UK
Paul Griffiths, EMCDDA Scientific Director
Dr Roumen Sedefov, Head of unit, Supply reduction and new trends, EMCDDA
Dr Ana Gallegos, Head of sector, Action on new drugs, EMCDDA
Dr Giovanni Martinotti, University of Chieti-Pescara
Dr Alessandro Vento, Guglielmo Marconi University
Prof Paolo Girardi, Sapienza University of Rome
Prof Giuseppe Bersani, Sapienza University of Rome
Prof Massimo di Giannantonio, University of Chieti-Pescara
Prof Luigi Janiri, Catholic University of Rome
Dr Giuseppe Ducci, San Filippo Neri Hospital
Prof. Sergio De Filippis
CONFERENCE VENUE
Dr Dario Carrus
Psichiatra - Dirigente Psichiatra, CSM Montefiascone, AUSL VT - Sapienza
University of Rome Sapienza University of Rome Roma, Italia
Dr Ornella Corazza
Psichiatra - Direttore Sanitario Casa di cura Neuropsichiatrica Villa Von Siebenthal
Villa von Siebenthal Roma, Italia
Prof Massimo di Giannantonio
Psichiatra - Docente Università degli Studi di Chieti, Facoltà di Psicologia,
Dipartimento di Scienze biomediche, University of Chieti - Pescara Chieti - Pescara,
Italia
DOMUS PACIS
Torre Rossa Park
Via di Torrerossa, 94 - 00165 Rome, Italy
Segreteria Organizzativa e Provider
Dr Giuseppe Ducci
Momeda Eventi srl
Via San Felice, 38 - 40122 Bologna
ph. +39 051 5876729 - Fax +39 051 5876848
[email protected] - www.momedaeventi.com
Prof. Andrea Fagiolini
DESTINATARI del Simposio
e accreditamento ECM
Dr Gilberto Di Petta
Psichiatra - Responsabile U.O.S.D. Doppia Diagnosi, Dipartimento Dipendenze ASL
Napoli 2 Nord ASL Napoli 2 Nord Napoli, Italia
Psichiatra - Direttore UOC SPDC San Filippo Neri, Roma San Filippo Neri Hospital,
Roma, Italia
Psichiatra - Professore associato Università di Siena, Direttore dipartimento
interaziendale di salute mentale Università di Siena, Siena, Italia
Dr Ana Gallegos
Chimico - European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
Head of sector, Action on new drugs, EMCDDA, CEE
Prof Paolo Girardi
Il corso è a numero chiuso e prevede un massimo di
150 partecipanti. E’ rivolto a Medici chirurghi (150)
specializzati in Psichiatria, Neurologia, Cardiologia,
Endocrinologia.
QUOTE di ISCRIZIONE:
Psichiatra - Professore Ordinario di Psichiatria, Direttore UOC di Psichiatria,
Azienda Ospedaliera Sant’Andrea, Facoltà di Medicina e Psicologia, La Sapienza
Università di Roma Sapienza, Roma, Italia
Figura professionale
Mr Paul Griffiths
Medico chirurgo
€ 250,00 + IVA
Medico in formazione/ Studenti
€ 150,00 + IVA
Epidemiologo - European Monitoring Centre for Drugs and Drug Addiction
(EMCDDA) EMCDDA Scientific Director, CEE
Prof Luigi Janiri
Cena sociale
Quota di iscrizione
€ 60,00 + IVA
Neurologo - Professore associato Facoltà di MEDICINA E CHIRURGIA Sede di Roma
Psichiatria e Psicologia Università La Cattolica di Roma, Roma, Italia
Dr Sabrina Levissianos
Economista - Associate Drug Control Officer at the United Nations Office on Drugs
and Crime (UNODC) - Global Synthetics Monitoring: Analyses, Reporting and Trends
(SMART) Programme UNODC CEE
Dr Giovanni Martinotti
Psichiatra - ricercatore presso Dipartimento di Neuroscienze Imaging, Università
degli studi di Chieti, “G. D’Annunzio” University of Chieti-Pescara Chieti, Pescara,
Italia
Sir Robin Murray
Psichiatra - Professor of Psychiatric Research at the Institute of Psychiatry, King’s
College London Kings College of London, London, UK
Prof Andy Parrott
Psichiatra - Professor in Department of Psychology, Swansea University UK, is an
international authority on the human psychobiology of MDMA or Ecstasy University
of Swansea, Swansea, UK
Prof Fabrizio Schifano
Psichiatra - Professore Ordinario di Farmacologia Clinica e Terapia, Faculty of
Health and Human Sciences, School of Pharmacy, University of Hertfordshire
(UK), Primario Psichiatra (Dipendenze), Servizio Tossicodipendenze e Alcolismo,
Hertfordshire (UK) University of Hertfordshire Hartfield, UK
Dr Roumen Sedefov
Psichiatra - European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
Head of unit, Supply reduction and new trends, EMCDDA CEE
Mr Harry Shapiro
Giornalista - Head of Publishing and Director of Communications Drugscope Cardiff,
UK
Dr Alessandro Vento
Psichiatra - Dirigente Psichiatra, ASL RMC, Dottorato di ricerca Università “La
Sapienza” Roma. Guglielmo Marconi University Roma, Italia
Prof Matthew Young
Psicologo - Senior Research and Policy Analyst at the Canadian Centre on Substance
Abuse (CCSA) - Adjunct Research Professor of Psychology at Carleton University in
Ottawa CCSA Ottawa, Canada
Con il contributo
non condizionato di

Download Report